Neuropathic pain (pain due to nerve damage)

Similar documents
KAISER PERMANENTE SPINE

Varicose Veins Surgery Questionnaire

Neuropathic Pain Treatment Guidelines

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Please return the questionnaire in the enclosed pre-paid envelope

Advice following an Independent Review Panel (IRP)

KAISER PERMANENTE SPINE

Analgesia in patients with impaired renal function Formulary Guidance

Neuropathic Pain in Palliative Care

BRIEF PAIN INVENTORY LONG FORM

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

London Pathway Evaluation

Palliative Prescribing - Pain

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Your Health Survey. Forename: Surname: Renal Unit: Type of treatment: If HD, are you: Date of birth: Home Post Code: Date completed: NHS number:

R Number. Patient Intake

Brief Pain Inventory (Short Form)

Pain Management Documents

Overview of Essentials of Pain Management. Updated 11/2016

Persistent Pain Resources. Ten Key Messages

Scottish Medicines Consortium

Discharge Information Following Surgery

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

Commissioning Policy Individual Funding Request

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

INFORMATION FOR PATIENTS. Let s Manage Pain

Gateshead Pain Guidelines for Chronic Conditions

MOTOR VEHICLE ACCIDENT PAIN CHART

Guidelines for the Pharmacological Management of Chronic Pain in Primary Care. December 2012

7 th November % of patients had lidocaine plasters prescribed for the licensed indication of post herpatic neuralgia

PRIMARY MANAGEMENT OF DRUG PRESCRIBING IN NON-MALIGNANT PAIN

Welcome to NHS Highland Pain Management Service

Patient Details Hidden. Clinical Enrollment. Quality of Life. EuroQOL (EQ-5D) Enroll Patient. Not Started. Not Started

16 year old with Disabling Chest Wall Pain after Thoracoscopic Talc Pleurodesis for Treatment of Recurrent Spontaneous Pneumothoraces

Neuropathic pain MID ESSEX LOCALITY

DATA COLLECTION SHEET CRF 3M FOLLOW UP AT 3 MONTHS (+/- 2 weeks)

Enhanced Community Palliative Support Services. Lynne Ghasemi St Luke s Hospice

London Pathway Evaluation

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Good. Poor [ ] [ ] Yes, at all [ A ] Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf [ ] [ ]

Daisy Cam. MS Specialist Nurse, Sheffield Teaching Hospitals NHS Foundation Trust

ARTIC PC. Diagnosis & treatment study Diary. Version 1 ( )

Knock Out Opioid Abuse in New Jersey:

If Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017

Management of post-stroke pain

Practical Management Of Osteoporosis

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

<</<</<<<< <</<</<<<< < << <<< * * *1* *TCO26* ! No Surgery or Treatment Scheduled Yet

Best Practice Guide: Pain

New service available for VoY Ryedale practice patients

Pain. Understand the causes and consequences of pain in myeloma patients

Pain Management in the

Coversheet for Network Site Specific Group Agreed Documentation

Persistent Pain in Secure Environments Health and Justice Pharmacy Network Meeting Tuesday 18 March 2014

GUIDELINE FOR MANAGING NEUROPATHIC PAIN IN PRIMARY CARE

A Phase II Study to Establish the Efficacy and Toxicity of Sodium Valproate in Patients With Cancer-Related Neuropathic Pain

Pregabalin Prescribing in Primary Care Audit Results 2012/13

Capsaicin cutaneous patch

Pain. Christine Illingworth. Community Nurse St Luke s Hospice 17/5/17

Regional Renal Training

DEPARTMENT OF NEUROSURGERY Spine Center New Patient Intake Form

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

Pain Assessment & Management. For General Nursing Orientation

Medications for the Treatment of Neuropathic Pain

Mesothelioma Outcomes, Research and Experience survey (MORE Survey).

The Socioeconomic Cost of Chronic Rhinosinusitis (SoCCoR) Study

Improving trial methodology: Examples from epilepsy. Tony Marson University of Liverpool

Neuropathic Pain. Griffith Research Online. Author. Published. Journal Title. Copyright Statement. Downloaded from. Link to published version

Other classical forms of neuropathic pain include diabetic peripheral neuropathy, trigeminal neuralgia and postherpetic

Suspected spinal cord compression form

I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4

Essential pain assessment. General tips. Pain history. History Examination Investigations

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

Practice Name. Audit Undertaken By and Job Title. Date of Audit

Appendix 4C: Guidance on the Management of Chronic Non- Malignant Pain

HealthPartners Inspire Special Needs Basic Care Clinical Care Planning and Resource Guide CHRONIC PAIN

Pain control in Cancer patients. Dr Ali Shoeibi, Assistant Professor of Neurology

Patient Outcome Scores (pre-op)

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am

USE THE LETTERS LISTED BELOW TO INDICATE

SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION

Monte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID

POLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy

Subject: Pain Management (Page 1 of 7)

Extended Aberdeen Spine Pain Scale

SCOPING DOCUMENT FOR WHO Treatment Guidelines on pain related to cancer, HIV and other progressive life-threatening illnesses in adults

CONCORD INTERNAL MEDICINE. Peripheral Neuropathy. April 22, 2012

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS

6 Months Observational Study

Management of neuropathic pain (non-malignant) Medicines Initiation Protocol

The Socioeconomic Cost of Chronic Rhinosinusitis (SoCCoR) Study

Berkshire West Area Prescribing Committee Guidance

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples

DANCER INTAKE FORM. 9. Do you teach dance? Yes No. If yes, how many hours a week do you teach? 10. Nightly sleep: Average of hours of sleep per night

Initial Patient Questionnaire

National Institute for Health and Care Excellence. Neuropathic pain - pharmacological management Guideline consultation. Stakeholder Comments

Evidence-based Clinical Practice Guidelines on Management of Pain in Older People Aza Abdulla, Margaret Bone, Nicola Adams, Alison M.

Patient Assessment Form

Transcription:

Neuropathic pain (pain due to nerve damage) Clinical Guideline Pain can be nociceptive, neuropathic or mixed. The neuropathic component of pain generally responds poorly to conventional analgesics. Consider a neuropathic element to the pain if this occurs. For key words in the history see FEATURES. The accompanying questionnaire can help make a neuropathic component more or less likely, but does not replace your clinical acumen. FEATURES Pain on gentle stimulation (allodynia) Burning/Stabbing/Tingling/ Numbness Shooting/Crawling/Pins & Needles Radiation of Pain See Pain scoring Questionnaires (In appendices 1, 2 and 3) Use appendices1 and 2 for baseline and follow up assessments. Use appendices 3 and 4 for follow up assessments. CAUSES Metabolic: - Diabetes / Alcohol / Chemical / Drugs Viral - Post-herpetic/AIDS Trauma - Injury/Surgery Compression - Sciatica /Brachalgia Idiopathic Malignancy Try to establish a diagnosis. Serious underlying disease may have to be excluded. Possible investigations include FBC/ U+E/ LFT/ TFT/ BS /B 12 / Folate/ ESR/ CRP/ X-rays/ Scans. Routine or urgent referral may be required. Success of treatment is in the 40-60% range Anxiety/depression and sleep disturbance can be significant Counselling/explanation will be an essential part of treatment All treatments have potential side-effects (sedation/dry mouth/constipation/ hangover`). If no contraindications, build up dose slowly allowing several days before changes - side-effects tend to lessen and the drug is better tolerated. Most patients will suffer side-effects; it is a balance between analgesia and side-effects. Review patients regularly for response to treatment Warn patients they may get side effects If drugs are not effective discontinue them and move to next step Continue to check patient s diagnosis and neurological status If management is still a problem refer to PAIN RELIEF CLINIC Approved by Medicines Clinical Guidelines SubCommittee: Feb 2013 Review by: Feb 2016 Page 1 of 11

Treatment Algorithm Primary & Secondary Care Encourage conventional analgesics as first step (non opioid, NSAID or mild to moderate opioid as per WHO ladder) - usually only partially effective. For poor response add in adjuvant analgesia. Step 1 Non diabetic patients Perform baseline assessment Prescribe: 1. Amitriptyline 10mg at night, increasing to 75mg at night if needed (especially if sleep disturbance) 2. Nortriptyline 10mg at night, increasing to 75mg at night if needed (if amitriptyline is effective but causing intolerable side effects) NB doses greater than 50mg offer limited additional analgesia but markedly increased side effects. Diabetic patients Step 2 Reassess patients after at least 1 month 1. Gabapentin (NB fast titration may be used in patient groups outlined below*) other groups require to be slowly titrated as per BNF. OR 2. Pregabalin 75mg twice daily for 2 weeks. Increasing to 150mg twice daily if inadequate response (use if gabapentin is not effective, or causing side effects). If not effective Duloxetine 60mg once daily. Reassess at 2 months and increase dose to 60mg twice daily If needed. Step 3 Reassess the patient after at least a month and add tramadol if needed. If this is not effective then refer for secondary care opinion. Refer to Treatment Algorithm for Secondary Care overleaf Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 2 of 11

Treatment Algorithm Secondary Care Only Step 4 Reassess the patient Consider capsaicin cream 0.075% regularly three or four times a day. Reassess response at six weeks (NB licensed for post herpetic neuralgia (PHN) and diabetic polyneuropathy only. OR Lidocaine patches 5% reassess response at 2 weeks and discontinue treatment after 4 weeks if poor response (NB licensed for PHN only). Step 5 Reassess patient and consider capsaicin 8% patch for patients with post herpatic neuralgia, Chronic post surgical, peripheral neuropathy, complex regional pain syndrome, compression neuropathy. NOTE: To be administered under the supervision of Dr Peter Williams only Step 6 Reassess patient and add in a strong opiate 1 st line Morphine OR 2 nd line Oxycodone (only if morphine is causing intolerable side effects, patient unresponsive to treatment, drug is not effective or if the patient has moderate to severe renal dysfunction CKD 4 or 5). Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 3 of 11

Prescribing es Amitriptyline versus Nortriptyline Amitryptyline is the most cost effective option of these 2 drugs and is used 1st line. If sleep affected, start with 10mg and increase dose until therapeutic effect reached (see notes above) or side effects not tolerated. If only small dose tolerated add in drug from step 2. Gabapentin/Pregabalin Gabapentin is the most cost effective option of these 2 drugs and is used 1 st line. *Gabapentin fast titration Gabapentin may be initiated in a dose of 300mg three times a day (fast titration) and adjusted in 300mg increments every 3 days if needed in all patients except : 1. Those under 12 or over 65 years old, 2. Those with renal dysfunction, 3. Patients with low body weight, 4. Patients post renal transplant. These groups need titration as per BNF. Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 4 of 11

APPENDIX 1 BRIEF PAIN INVENTORY (To be used at baseline AND follow up assessments) Name C/S Date Throughout our lives, most of us have had everyday types of pain from time to time such as minor headaches, sprains and toothache. Have you had pain other than these everyday types of pain during the last week? YES NO On the diagram, shade in the area[s] where you feel pain. Put an X on the area that hurts the most. Please rate your pain by circling the one number that best describes your pain at its WORST in the last week. No Pain Pain as bad as you can imagine Please rate your pain by circling the one number that best describes your pain at its LEAST in the last week. No Pain Pain as bad as you can imagine Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 5 of 11

Please rate your pain by circling the one number that best describes your pain ON AVERAGE. No Pain Pain as bad as you can imagine Please rate your pain by circling the one number that best describes your pain RIGHT NOW. No Pain Pain as bad as you can imagine Circle the one number that describes how, during the last week, pain has interfered with your - GENERAL ACTIVITY s MOOD s WALKING ABILITY s NORMAL WORK [includes both work outside the home and housework] s Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 6 of 11

RELATIONS WITH OTHER PEOPLE s SLEEP s ENJOYMENT OF LIFE s Have you received any treatments for your pain [for example, physiotherapy] or taken any medications on a regular basis for your pain [for example, painkillers] within the last week? YES NO If you have received any treatments for your pain or taken any medications on a regular basis for your pain within the last week, how much relief, if any, have these treatments or regular medications provided? Please circle the one percentage that most shows how much RELIEF you have received. 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% No Complete Relief Relief Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 7 of 11

APPENDIX 2 EUROQOL 5D HEALTH QUESTIONNAIRE (To be used for baseline and follow up assessments) Name C/S Date By placing a tick in one box in each group below, please indicate which statements best describe your own health state today Mobility I have had no problems in walking about I have had some problems in walking about I have been confined to bed Self-Care I have had no problems with self-care I have had some problems washing or dressing myself I have been unable to wash or dress myself Usual Activities (e.g. work, study, housework, family or leisure activities) I have had no problems with performing my usual activities I have had some problems with performing my usual activities I have been unable to perform my usual activities Pain/Discomfort I have had no pain or discomfort I have had moderate pain or discomfort I have suffered extreme pain or discomfort Anxiety/Depression I have not been anxious or depressed I have been moderately anxious or depressed I have been extremely anxious or depressed Please turn page over Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 8 of 11

To help people say how good or bad a health state is, we have drawn a scale (rather like a thermometer) on which the best state you can imagine is marked 100 and the worst state you can imagine is marked 0. We would like you to indicate on this scale how good or bad your own health is today, in your opinion. Please do this by drawing a line at whichever point on the scale indicates how good or bad your health state is. Best imaginable health state 100 9 0 8 0 7 0 Your own health state today 6 0 5 0 4 0 Pain Clinic Use Only Mobility Self-Care 3 0 2 0 Usual Activities Pain/Discomfort 1 0 Anxiety/Depression EQ-5D Health Thermometer Scoring 1-2-3 0 Worst imaginable health state Approved by Wirral Drug & Therapeutics Panel: Oct 2013 Review by: Oct 2016 Page 9 of 11

APPENDIX 3 Patient Global Impression Of Change (To be used at follow up assessments in primary & secondary care) Name C/S Date Since you commenced treatment at Wirral University Teaching Hospital NHS Foundation Trust Chronic Pain Management Clinic, please indicate how your pain condition and quality of life has changed by ticking the appropriate box Pain Condition and Quality of Life Very Much Improved Much Improved Minimally Improved No Change Minimally Worse Much Worse Very Much Worse Thank you Approved by Medicines Clinical Guidelines SubCommittee: Feb 2013 Review by: Feb 2016 Page 10 of 11

APPENDIX 4 Clinician Global Impression Of Change (To be used at follow up assessments in primary & secondary care) Patient s Name C/S Date Since the above named patient commenced treatment at Wirral University Teaching Hospital NHS Foundation Trust Chronic Pain Management Clinic, please indicate how you believe that his/her Pain status and Quality of Life has changed by ticking the appropriate box Pain Condition and Quality of Life Very Much Improved Much Improved Minimally Improved No Change Minimally Worse Much Worse Very Much Worse Thank you Approved by Medicines Clinical Guidelines SubCommittee: Feb 2013 Review by: Feb 2016 Page 11 of 11